Dysmetabolic iron overload syndrome: A systemic disease?;Hépatosidérose dysmétabolique: Une maladie générale?

Presse Medicale

Volumn 43, Issue 6P1, 2014, Pages 625-627

  Deugnier, Yves ^a   Lainé, Fabrice ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HUMAN; IRON OVERLOAD; LABORATORY DIAGNOSIS; LIVER HEMOSIDEROSIS; DYSMETABOLIC IRON OVERLOAD SYNDROME; SYSTEMIC DISEASE;

ANIMALS; FATTY LIVER; HEMOSIDEROSIS; HUMANS; IRON OVERLOAD; LIVER CIRRHOSIS; LIVER DISEASES; MICE; MICE, INBRED C57BL; PHLEBOTOMY;

EID: 84902545015     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2014.03.008     Document Type: Editorial

References (10)

1. Moirand R., Mortaji A.M., Loreal O., Paillard F., Brissot P., Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet 1997, 349:95-97.
2. Mendler M.H., Turlin B., Moirand R., Jouanolle A.M., Sapey T., Guyader D., et al. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999, 117:1155-1163.
3. Deugnier Y., Turlin B. Pathology of hepatic iron overload. Semin Liver Dis 2011, 31:260-271.
4. Dongiovanni P., Fracanzani A.L., Fargion S., Valenti L. Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target. J Hepatol 2011, 55:920-932.
5. Le Lan C., Mosser A., Ropert M., Detivaud L., Loustaud-Ratti V., Vital-Durand D., et al. Sex and acquired cofactors determine phenotypes of ferroportin disease. Gastroenterology 2011, 140:1199-1207.
6. Dongiovanni P., Ruscica M., Rametta R., Recalcati S., Steffani L., Gatti S.J., et al. Dietary iron overload induces visceral adipose tissue insulin resistance. Am Pathol 2013, 182:2254-2263.
7. Orr J.S., Kennedy A., Anderson-Baucum E.K., Webb C.D., Fordahl S.C., Erikson K.M., et al. Obesity alters adipose tissue macrophage iron content and tissue iron distribution. Diabetes 2014, 63:421-432.
8. Vecchi C., Montosi G., Garuti C., Corradini E., Sabelli M., Canali S., et al. Gluconeogenic signals regulate iron homeostasis via hepcidin in mice. Gastroenterology 2014, 146:1060-1069.
9. Aigner E., Theurl I., Haufe H., Seifert M., Hohla F., Scharinger L., et al. Copper availability contributes to iron perturbations in human non-alcoholic fatty liver disease. Gastroenterology 2008, 135:680-688.
10. Zacharski L.R., Chow B.K., Howes P.S., Shamayeva G., Baron J.A., Dalman R.L., et al. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst 2008, 100:996-1002.